These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 17089033)

  • 1. The expression profiles of orotate phosphoribosyltransferase and dihydropyrimidine dehydrogenase in gastric cancer and their clinical significance.
    Oeda M; Yoshida K; Sanada Y; Wada Y; Suzuki T; Mizuiri H; Konishi K; Shigematsu H; Tanabe K; Fukushima M
    Oncol Rep; 2006 Dec; 16(6):1165-72. PubMed ID: 17089033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profile of 5-fluorouracil metabolic enzymes in primary colorectal cancer: potential as predictive parameters for response to fluorouracil-based chemotherapy.
    Kinoshita M; Kodera Y; Hibi K; Nakayama G; Inoue T; Ohashi N; Ito Y; Koike M; Fujiwara M; Nakao A
    Anticancer Res; 2007; 27(2):851-6. PubMed ID: 17465211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy.
    Yamada H; Iinuma H; Watanabe T
    Oncol Rep; 2008 Mar; 19(3):729-35. PubMed ID: 18288408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase mRNA and protein expression levels in solid tumors in large scale population analysis.
    Fukui Y; Oka T; Nagayama S; Danenberg PV; Danenberg KD; Fukushima M
    Int J Mol Med; 2008 Dec; 22(6):709-16. PubMed ID: 19020767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and prognostic significance of protein and gene expression of orotate phosphoribosyltransferase in gastric carcinoma].
    Sakurai Y; Yoshida I; Tonomura S; Inaba K; Shoji M; Nakamura Y; Uyama I; Komori Y; Ochiai M; Kamoshida S; Tsutsumi Y
    Gan To Kagaku Ryoho; 2006 Aug; 33(8):1111-8. PubMed ID: 16912530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical role of orotate phosphoribosyl transferase and dihydropyrimidine dehydrogenase in colorectal cancer treated with postoperative fluoropyrimidine.
    Tokunaga Y; Sasaki H; Saito T
    Surgery; 2007 Mar; 141(3):346-53. PubMed ID: 17349846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of orotate phosphoribosyl transferase in hormone-refractory prostate cancer.
    Tanaka T; Kawashima H; Matsumura K; Yamashita-Hosono T; Yoshimura R; Kuratsukuri K; Harimoto K; Nakatani T
    Oncol Rep; 2009 Jan; 21(1):33-7. PubMed ID: 19082440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymidylate synthase expression in oral squamous cell carcinoma predicts response to S-1.
    Harada K; Kawashima Y; Yoshida H; Sato M
    Oncol Rep; 2006 Jun; 15(6):1417-23. PubMed ID: 16685374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of dihydropyrimidine dehydrogenase in cancer cells but not in stromal cells predicts the efficacy of fluorouracil treatment in patients with gastric carcinoma.
    Hisamitsu K; Tsujitani S; Yamaguchi K; Fukuda K; Konishi I; Kaibara N
    Anticancer Res; 2004; 24(4):2495-501. PubMed ID: 15330204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative double-fluorescence immunohistochemistry (qDFIHC), a novel technology to assess protein expression: a pilot study analyzing 5-FU sensitive markers thymidylate synthase, dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferases in gastric cancer tissue specimens.
    Kai K; Kitajima Y; Hiraki M; Satoh S; Tanaka M; Nakafusa Y; Tokunaga O; Miyazaki K
    Cancer Lett; 2007 Dec; 258(1):45-54. PubMed ID: 17892912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of mRNA levels of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase of colorectal cancer--relationships among mRNA levels in association with response to 5-FU based treatment].
    Ishida H; Shirakawa K; Ohsawa T; Sobajima J; Hayashi Y; Nakada H; Yokoyama M; Hashimoto D
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1929-34. PubMed ID: 16282729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Kornmann M; Schwabe W; Sander S; Kron M; Sträter J; Polat S; Kettner E; Weiser HF; Baumann W; Schramm H; Häusler P; Ott K; Behnke D; Staib L; Beger HG; Link KH
    Clin Cancer Res; 2003 Sep; 9(11):4116-24. PubMed ID: 14519634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical dihydropyrimidine dehydrogenase expression is a good prognostic indicator for patients with Dukes' C colorectal cancer.
    Oi K; Makino M; Ozaki M; Takemoto H; Yamane N; Nakamura S; Ikeguchi M; Kaibara N
    Anticancer Res; 2004; 24(1):273-9. PubMed ID: 15015608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations of clinicopathological factors with protein expression levels of thymidylate synthase, dihydropyrimidine dehydrogenase and orotate phosphoribosyltransferase in colorectal cancer.
    Sumi T; Katsumata K; Tsuchida A; Ishizaki T; Shimazu M; Aoki T
    Chemotherapy; 2010; 56(2):120-6. PubMed ID: 20407238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical demonstration of fluoropyrimidine-metabolizing enzymes in various types of cancer.
    Kamoshida S; Shiogama K; Shimomura R; Inada K; Sakurai Y; Ochiai M; Matuoka H; Maeda K; Tsutsumi Y
    Oncol Rep; 2005 Nov; 14(5):1223-30. PubMed ID: 16211289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression of 5-fluorouracil metabolic enzymes in primary colorectal cancer and corresponding liver metastasis.
    Inokuchi M; Uetake H; Shirota Y; Yamada H; Tajima M; Sugihara K
    Cancer Chemother Pharmacol; 2004 May; 53(5):391-6. PubMed ID: 15060742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent S-1-based neoadjuvant/adjuvant chemotherapy].
    Sakurai Y; Kamoshida S; Furuta S; Sunagawa R; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y
    Gan To Kagaku Ryoho; 2008 Jul; 35(7):1147-55. PubMed ID: 18633253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High intratumoral dihydropyrimidine dehydrogenase mRNA levels in pancreatic cancer associated with a high rate of response to S-1.
    Kuramochi H; Hayashi K; Uchida K; Nakajima G; Hatori T; Danenberg KD; Danenberg PV; Yamamoto M
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):85-9. PubMed ID: 18309485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of prophylactic hepatic arterial chemotherapy for liver metastases of Dukes C colorectal cancer--correlation with tumoral expression of dihydropyrimidine dehydrogenase, thymidylate synthase, p53, or orotate phosphoribosyl transferase].
    Ishida H; Yamada H; Shirakawa K; Nakada H; Ohsawa T; Takeuchi I; Okada N; Yokoyama M; Inokuma S; Suzuki T; Odaka A; Hoshino T; Murata N; Hashimoto D; Itoyama S; Mori T; Matsumoto Y; Miura T
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1621-6. PubMed ID: 14619479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.